{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:33:49Z","timestamp":1792146829423,"version":"4.4.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001219","name":"Lymphoma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI164709"],"award-info":[{"award-number":["AI164709"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA228700"],"award-info":[{"award-number":["CA228700"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 AI137337"],"award-info":[{"award-number":["RO1 AI137337"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.coviro.2021.11.013","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T22:01:19Z","timestamp":1638914479000},"page":"78-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Epigenetic control of the Epstein-Barr lifecycle"],"prefix":"10.1016","volume":"52","author":[{"given":"Rui","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin E","family":"Gewurz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2021.11.013_bib0005","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.chom.2013.11.009","article-title":"Epstein-Barr viral productive amplification reprograms nuclear architecture, DNA replication, and histone deposition","volume":"14","author":"Chiu","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2021.11.013_bib0010","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1128\/JVI.06314-11","article-title":"The lytic phase of epstein-barr virus requires a viral genome with 5-methylcytosine residues in CpG sites","volume":"86","author":"Kalla","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.11.013_bib0015","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1073\/pnas.0911948107","article-title":"AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome","volume":"107","author":"Kalla","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.11.013_bib0020","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/ng1424","article-title":"The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome","volume":"36","author":"Bhende","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.coviro.2021.11.013_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001114","article-title":"CpG-methylation regulates a class of Epstein-Barr virus promoters","volume":"6","author":"Bergbauer","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.11.013_bib0030","article-title":"Epstein-barr virus","volume":"vol 2","author":"Gewurz","year":"2021"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0035","doi-asserted-by":"crossref","first-page":"16046","DOI":"10.1073\/pnas.1901314116","article-title":"Epstein-Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection","volume":"116","author":"Mrozek-Gorska","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0040","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.cmet.2019.06.003","article-title":"Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation","volume":"30","author":"Wang","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.coviro.2021.11.013_bib0045","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0042-6822(91)90893-G","article-title":"Early events in Epstein-Barr virus infection of human B lymphocytes","volume":"181","author":"Alfieri","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2021.11.013_bib0050","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1128\/JVI.73.5.4481-4484.1999","article-title":"The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2","volume":"73","author":"Kaiser","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0055","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00226-19","article-title":"RNA sequencing analyses of gene expression during Epstein-Barr virus infection of primary B lymphocytes","volume":"93","author":"Wang","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.11.013_bib0060","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.chom.2010.11.004","article-title":"An ATM\/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells","volume":"8","author":"Nikitin","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0065","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01723-19","article-title":"First days in the life of naive human B lymphocytes infected with Epstein-Barr virus","volume":"10","author":"Pich","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008590","article-title":"EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice","volume":"16","author":"Li","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0075","doi-asserted-by":"crossref","first-page":"26318","DOI":"10.1073\/pnas.2007946117","article-title":"Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2A","volume":"117","author":"Fish","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.11.013_bib0080","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/v5010226","article-title":"Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr virus","volume":"5","author":"Westhoff Smith","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2021.11.013_bib0085","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"The Cancer Genome Atlas Research Network","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2021.11.013_bib0090","doi-asserted-by":"crossref","first-page":"11442","DOI":"10.1128\/JVI.00972-14","article-title":"Genome-wide DNA methylation as an epigenetic consequence of Epstein-Barr virus infection of immortalized keratinocytes","volume":"88","author":"Birdwell","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0095","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1182\/bloodadvances.2020001511","article-title":"CpG methylation in cell-free Epstein-Barr virus DNA in patients with EBV-Hodgkin lymphoma","volume":"4","author":"Shamay","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.coviro.2021.11.013_bib0100","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1128\/jvi.63.7.3135-3141.1989","article-title":"5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt\u2019s lymphoma line rael","volume":"63","author":"Masucci","year":"1989","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.11.013_bib0105","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.15.11.6150","article-title":"Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial","volume":"15","author":"Robertson","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.coviro.2021.11.013_bib0110","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-12-125","article-title":"Methylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins","volume":"12","author":"Li","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0115","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/blood.2019004126","article-title":"Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapy","volume":"135","author":"Dalton","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2021.11.013_bib0120","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood-2009-08-239186","article-title":"Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients","volume":"115","author":"Heslop","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2021.11.013_bib0125","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1172\/JCI121127","article-title":"Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation","volume":"130","author":"Prockop","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0130","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s41564-020-0724-y","article-title":"DNA methylation enzymes and PRC1 restrict B-cell Epstein-Barr virus oncoprotein expression","volume":"5","author":"Guo","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.coviro.2021.11.013_bib0135","doi-asserted-by":"crossref","first-page":"e01987","DOI":"10.1128\/JVI.01987-16","article-title":"Restricted TET2 expression in germinal center type B cells promotes stringent Epstein-Barr virus latency","volume":"91","author":"Wille","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.11.013_bib0140","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00804-17","article-title":"Coordinate regulation of TET2 and EBNA2 controls the DNA methylation state of latent Epstein-Barr virus","volume":"91","author":"Lu","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.11.013_bib0145","doi-asserted-by":"crossref","first-page":"E7257","DOI":"10.1073\/pnas.1513432112","article-title":"5-hydroxymethylation of the EBV genome regulates the latent to lytic switch","volume":"112","author":"Wille","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0150","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01332-19","article-title":"Epstein-Barr virus infection promotes epithelial cell growth by attenuating differentiation-dependent exit from the cell cycle","volume":"10","author":"Eichelberg","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2021.11.013_bib0155","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/ng.3291","article-title":"Whole-genome fingerprint of the DNA methylome during human B cell differentiation","volume":"47","author":"Kulis","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.coviro.2021.11.013_bib0160","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1111\/febs.14934","article-title":"TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells","volume":"286","author":"Schoeler","year":"2019","journal-title":"FEBS J"},{"key":"10.1016\/j.coviro.2021.11.013_bib0165","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1101\/gr.155473.113","article-title":"DNA methylation profiling in human B cells reveals immune regulatory elements and epigenetic plasticity at Alu elements during B-cell activation","volume":"23","author":"Lai","year":"2013","journal-title":"Genome Res"},{"key":"10.1016\/j.coviro.2021.11.013_bib0170","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10875-016-0240-2","article-title":"Genetic, cellular and clinical features of ICF syndrome: a French national survey","volume":"36","author":"Sterlin","year":"2016","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coviro.2021.11.013_bib0175","doi-asserted-by":"crossref","first-page":"14350","DOI":"10.1128\/JVI.01895-14","article-title":"Viral reprogramming of the Daxx histone H3.3 chaperone during early Epstein-Barr virus infection","volume":"88","author":"Tsai","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.11.013_bib0180","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12707","article-title":"Structural basis underlying viral hijacking of a histone chaperone complex","volume":"7","author":"Huang","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2021.11.013_bib0185","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14257","article-title":"Epstein-Barr virus particles induce centrosome amplification and chromosomal instability","volume":"8","author":"Shumilov","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0190","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01063-20","article-title":"Histone loaders CAF1 and HIRA restrict Epstein-Barr virus B-cell lytic reactivation","volume":"11","author":"Zhang","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0195","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.molcel.2020.03.025","article-title":"MYC controls the Epstein-Barr virus lytic switch","volume":"78","author":"Guo","year":"2020","journal-title":"Mol Cell"},{"key":"10.1016\/j.coviro.2021.11.013_bib0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007070","article-title":"Continuous DNA replication is required for late gene transcription and maintenance of replication compartments in gammaherpesviruses","volume":"14","author":"Li","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0205","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1093\/nar\/gkab099","article-title":"Epstein-Barr virus inactivates the transcriptome and disrupts the chromatin architecture of its host cell in the first phase of lytic reactivation","volume":"49","author":"Buschle","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0210","doi-asserted-by":"crossref","first-page":"24630","DOI":"10.1073\/pnas.1913992116","article-title":"Four-dimensional analyses show that replication compartments are clonal factories in which Epstein-Barr viral DNA amplification is coordinated","volume":"116","author":"Nagaraju","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.11.013_bib0215","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01413-17","article-title":"The Epstein-Barr virus episome maneuvers between nuclear chromatin compartments during reactivation","volume":"92","author":"Moquin","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0220","article-title":"Epigenetic specifications of host chromosome docking sites for latent Epstein-Barr virus","volume":"11","author":"Kim","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0225","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01390-20","article-title":"Epstein-Barr virus episome physically interacts with active regions of the host genome in lymphoblastoid cells","volume":"94","author":"Wang","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.11.013_bib0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002902","article-title":"BZLF1 governs CpG-methylated chromatin of Epstein-Barr virus reversing epigenetic repression","volume":"8","author":"Woellmer","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.11.013_bib0235","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1128\/JVI.06768-11","article-title":"Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells","volume":"86","author":"Murata","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009447","article-title":"A heterochromatin inducing protein differentially recognizes self versus foreign genomes","volume":"17","author":"Burton","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0245","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cell.2020.12.022","article-title":"Cell-cycle-dependent EBNA1-DNA crosslinking promotes replication termination at oriP and viral episome maintenance","volume":"184","author":"Dheekollu","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2021.11.013_bib0250","doi-asserted-by":"crossref","DOI":"10.1186\/1743-422X-7-262","article-title":"Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1)","volume":"7","author":"Lu","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.coviro.2021.11.013_bib0255","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1128\/JVI.02318-15","article-title":"Identification of MEF2B, EBF1, and IL6R as direct gene targets of Epstein-Barr virus (EBV) nuclear antigen 1 critical for EBV-infected B-lymphocyte survival","volume":"90","author":"Tempera","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.11.013_bib0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009208","article-title":"A multi-omics approach to Epstein-Barr virus immortalization of B-cells reveals EBNA1 chromatin pioneering activities targeting nucleotide metabolism","volume":"17","author":"Lamontagne","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.11.013_bib0265","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1099\/vir.0.007344-0","article-title":"Binding of CCCTC-binding factor in vivo to the region located between Rep* and the C promoter of Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activity","volume":"90","author":"Salamon","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2021.11.013_bib0270","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.chom.2012.06.008","article-title":"An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions","volume":"12","author":"Arvey","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2021.11.013_bib0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002180","article-title":"EBV latency types adopt alternative chromatin conformations","volume":"7","author":"Tempera","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.11.013_bib0280","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1128\/JVI.05923-11","article-title":"Contributions of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr virus restricted latency","volume":"86","author":"Hughes","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0285","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01215-20","article-title":"The BHLF1 locus of Epstein-Barr virus contributes to viral latency and B-cell immortalization","volume":"94","author":"Yetming","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.11.013_bib0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001048","article-title":"CTCF prevents the epigenetic drift of EBV latency promoter Qp","volume":"6","author":"Tempera","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.11.013_bib0295","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00755-18","article-title":"PARP1 stabilizes CTCF binding and chromatin structure to maintain Epstein-Barr virus latency type","volume":"92","author":"Lupey-Green","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009764","article-title":"Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses and their elimination","volume":"17","author":"Biswas","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.11.013_bib0305","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1128\/JVI.02781-14","article-title":"Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters","volume":"89","author":"Reusch","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.11.013_bib0310","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01178-17","article-title":"c-Myc represses transcription of Epstein-Barr virus latent membrane protein 1 early after primary B cell infection","volume":"92","author":"Price","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0315","doi-asserted-by":"crossref","first-page":"14421","DOI":"10.1073\/pnas.1921139117","article-title":"Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesis","volume":"117","author":"Sommermann","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009419","article-title":"Epstein-Barr virus nuclear antigen 3C (EBNA3C) interacts with the metabolism sensing C-terminal binding protein (CtBP) repressor to upregulate host genes","volume":"17","author":"Ohashi","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0325","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01209-20","article-title":"Epstein-Barr virus facilitates expression of KLF14 by regulating the cooperative binding of the E2F-Rb-HDAC complex in latent infection","volume":"94","author":"Pei","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009783","article-title":"Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells","volume":"17","author":"Van Sciver","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0335","article-title":"The RNA quality control pathway nonsense-mediated mRNA decay targets cellular and viral RNAs to restrict KSHV","volume":"11","author":"Zhao","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001097","article-title":"Nonsense-mediated decay controls the reactivation of the oncogenic herpesviruses EBV and KSHV","volume":"19","author":"van Gent","year":"2021","journal-title":"PLoS Biol"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007796","article-title":"EBV epitranscriptome reprogramming by METTL14 is critical for viral-associated tumorigenesis","volume":"15","author":"Lang","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0350","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050128","article-title":"N(6)-methyladenosine-binding protein YTHDF1 suppresses EBV replication and promotes EBV RNA decay","volume":"22","author":"Xia","year":"2021","journal-title":"EMBO Rep"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0355","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01706-21","article-title":"Caspases switch off the m(6)A RNA modification pathway to foster the replication of a ubiquitous human tumor virus","volume":"12","author":"Zhang","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2021.11.013_bib0360","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1016\/j.celrep.2017.11.071","article-title":"B cell receptor activation and chemical induction trigger caspase-mediated cleavage of PIAS1 to facilitate epstein-barr virus reactivation","volume":"21","author":"Zhang","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.coviro.2021.11.013_bib0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006596","article-title":"Deregulation of KSHV latency conformation by ER-stress and caspase-dependent RAD21-cleavage","volume":"13","author":"De Leo","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0370","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1073\/pnas.1919133117","article-title":"A promiscuous inflammasome sparks replication of a common tumor virus","volume":"117","author":"Burton","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.11.013_bib0375","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2115508118","article-title":"The Epstein-Barr virus noncoding RNA EBER2 transactivates the UCHL1 deubiquitinase to accelerate cell growth","volume":"118","author":"Li","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0380","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022495118","article-title":"Monocarboxylate transporter antagonism reveals metabolic vulnerabilities of viral-driven lymphomas","volume":"118","author":"Bonglack","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.11.013_sbref0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008030","article-title":"Epstein-Barr virus subverts mevalonate and fatty acid pathways to promote infected B-cell proliferation and survival","volume":"15","author":"Wang","year":"2019","journal-title":"PLoS Pathog"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187962572100153X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187962572100153X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:09:53Z","timestamp":1761818993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187962572100153X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":77,"alternative-id":["S187962572100153X"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2021.11.013","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic control of the Epstein-Barr lifecycle","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2021.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}